TrademarkDir
ROXYBOND
DEAD

Serial Number

90837636

Owner

OHEMO LIFE SCIENCES INC.

Attorney

William E. Beaumont

First Use Date

Jun 7, 2022

Filing Date

Jul 20, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ROXYBOND Trademark

Serial Number: 90837636

ROXYBOND is a trademark filed by OHEMO LIFE SCIENCES INC. on July 20, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

OHEMO LIFE SCIENCES INC. (22 trademarks)

CARR. 198 KM 14.7 # 100
JUNCOS, PR 007773873

Entity Type: 03

Trademark Details

Filing Date

July 20, 2021

Registration Date

Not Registered

First Use Anywhere

June 7, 2022

First Use in Commerce

June 7, 2022

Goods & Services

pain relief medication featuring a bonded-layered formulation of oxycodone immediate release which is resistant to tampering to inhibit abuse

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 17, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 17, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 17, 2023 ABN2
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Dec 30, 2022 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Dec 30, 2022 RDX1
SUBSEQUENT FINAL REFUSAL WRITTEN
Dec 30, 2022 CFRC
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Dec 14, 2022 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Dec 14, 2022 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Dec 14, 2022 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 10, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 10, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 10, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 19, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 19, 2022 ERFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2022 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2022 TEME
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 14, 2022 ERFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 13, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 13, 2022 ERFR
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Sep 7, 2022 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Sep 7, 2022 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Sep 7, 2022 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 10, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 10, 2022 ERFR
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jul 27, 2022 AAUA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 26, 2022 GNFN
FINAL REFUSAL E-MAILED
Jul 26, 2022 GNFR
FINAL REFUSAL WRITTEN
Jul 26, 2022 CNFR
USE AMENDMENT ACCEPTED
Jul 26, 2022 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Jun 22, 2022 AUPC
USE AMENDMENT FILED
Jun 22, 2022 IUAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2022 TROA
TEAS AMENDMENT OF USE RECEIVED
Jun 21, 2022 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 13, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 13, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 13, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 13, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2021 NWOS
NEW APPLICATION ENTERED
Jul 23, 2021 NWAP

Related Trademarks

More from this Owner

SENTRYBOND

SENTRYBOND

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED - RELEASE TABLETS logo

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED - RELEASE TABLETS

MORPHABOND ER

MORPHABOND ER

ROXYBOND

ROXYBOND

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED-RELEASE TABLETS logo

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED-RELEASE TABLETS

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED-RELEASE TABLETS logo

MORPHABOND · ER (MORPHINE SULFATE) EXTENDED-RELEASE TABLETS